Hepatocellular carcinoma in hepatitis D: Does it differ from hepatitis B monoinfection

Saudi Journal of Gastroenterology

Volumn 18, Issue 1, 2012, Pages 18-22

  Abbas, Zaigham ^a   Qureshi, Mustafa ^a   Hamid, Saeed ^a   Jafri, Wasim ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

hepatitis B; hepatitis D; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS ANTIBODY;

ADULT; AGED; ARTICLE; ASCITES; BIOCHEMICAL COMPOSITION; BODY MASS; CLINICAL FEATURE; DELTA AGENT HEPATITIS; DISEASE SEVERITY; ENDOSCOPY; FEMALE; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SUPERINFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; ENDOSCOPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS D; HUMANS; HYPERTENSION, PORTAL; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PAKISTAN; STATISTICS, NONPARAMETRIC;

EID: 84856449212     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.91731     Document Type: Article

References (33)

1. Wursthorn K, Manns MP, Wedemeyer H. Natural history: The importance of viral load, liver damage and HCC. Best Pract Res Clin Gastroenterol 2008;22:1063-79.
2. Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAgseroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002;123:1084-9.
3. Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafri W. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. J Pak Med Assoc 2009;59:434-7.
4. Rizzetto M, Canese M, Aricò S. Immunofluorescence detection of a new antigen antibody system (delta/anti-delta) associated to hepatitis B virus in liver and serum of HBsAg carriers. Gut 1977;18:997-1003. (Pubitemid 8263407)
5. Gaeta B, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, et al. Chronic hepatitis D: A vanishing Disease? An Italian multicenter study. Hepatology 2000;32:824-7.
6. Deǧertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: A meta-analysis. Liver Int 2008;28:494-8. (Pubitemid 351411135)
7. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan: An analysis of contributory factors. J Gastroenterol Hepatol 1997;12:747-51.
8. Abbas Z, Jafri W, Raza S. Delta hepatitis in Asia Pacific Region-Review. World J Gastroenterol 2010;16:554-62.
9. Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S, et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol 2005;20:1503-7. (Pubitemid 43961102)
10. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000;46:420-6. (Pubitemid 30313398)
11. Tamura I, Kurimura O, Koda T, Ichimura H, Katayama S, Kurimura T, et al. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: A study from Kure, Japan. J Gastroenterol Hepatol 1993;8:433-6. (Pubitemid 23271816)
12. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, Smith HM, et al. The increasing prevalence of hepatitis D virus (HDV) infection in South London. J Med Virol 2008;80:277-82.
13. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, et al. A 28-year study of the course of hepatitis delta infection: A risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009;136:1629-38.
14. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
15. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28. (Pubitemid 15228292)
16. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999;19:329-38.
17. Greene FL, Page DL, Fleming ID, editors. AJCC Cancer Staging Manual. 6th ed. New York: Springer Verlag Inc.; 2002.
18. Kratzer W, Fritz V, Mason RA, Haenle MM, Kaechele V; Roemerstein Study Group. Factors affecting liver size: A sonographic survey of 2080 subjects. J Ultrasound Med 2003;22:1155-61. (Pubitemid 37356545)
19. Miller LS, Schiano TD, Adrain A, Cassidy M, Liu JB, Ter H, et al. Comparison of high resolution endoluminalsonography to video endoscopy in the detection of esophageal varices. Hepatology 1996;24:552-5. (Pubitemid 26295996)
20. Kane L, Kahaleh M, Shami VM, Caldwell SH, Berg CL, Abdrabbo KM, et al. Comparison of the grading of esophageal varices by transnasalendoluminal ultrasound and esophagogastroduodenoscopy. Clin Gastroenterol Hepatol 2005;3:806-10. (Pubitemid 41116734)
21. Ryu WS. Molecular aspects of hepatitis B viral infection and the viral carcinogenesis. J Biochem Mol Biol 2003;36:138-43.
22. Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R, et al. Natural history of compensated viral B and D cirrhosis. Rom J Gastroenterol 2005;14:329-35. (Pubitemid 43027120)
23. Yurdayd?n C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat 2010;17:749-56.
24. Su CW, Huang YH, Huo TI, Shih HH, Sheen IJ, Chen SW, et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 2006;130:1625-35. (Pubitemid 43668837)
25. Niro GA, Smedile S, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 1997;25:728-34. (Pubitemid 27106461)
26. Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol 2007;13:2604-7. (Pubitemid 46938832)
27. Abbas Z, Muzaffar R, Siddiqui A, Naqvi SA, Rizvi SA. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi. BMC Gastroenterol 2006;6:20.
28. Oliveri F, Brunetto MR, Actis GC, Bonino F. Pathobiology of chronic hepatitis virus infection and hepatocellular carcinoma (HCC). Ital J Gastroenterol 1991;23:498-502.
29. Verme G, Brunetto MR, Oliveri F, Baldi M, Forzani B, Piantino P, et al. Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci 1991;36:1134-6.
30. Brunetto MR, Oliveri F, Colombatto P, Bonino F. Hepatocellular carcinoma and infections with multiple hepatitis viruses. Princess Takamatsu Symp 1995;25:61-6.
31. Ikeda K, Arase Y, Kobayashi M, Someya T, Saitoh S, Suzuki Y, et al. Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV related cirrhosis. A nested case-control study using 96 untreated patients. Intervirology 2003;46:96-104. (Pubitemid 36407926)
32. Sagnelli E, Felaco FM, Rapicetta M, Stroffolini T, Petruzziello A, Annella T, et al. Interaction between HDV and HBV infection in HbsAgchronic carriers. Infection 1991;19:155-8.
33. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001;34:404-10. (Pubitemid 32702354)